FDA Adverse Event Malfunction Summary report: N

ENDOTAK RELIANCE

MDR report key: 3043205 · Received April 9, 2013

Report

Report Number
2124215-2013-01809
Event Type
Malfunction
Date Received
April 9, 2013
Date of Event
January 18, 2013
Report Date
January 17, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

A BOSTON SCIENTIFIC TECHNICAL SERVICES CONSULTANT DISCUSSED THE REPORTED CLINICAL OBSERVATIONS WITH THE CALLER. IT WAS REPORTED THAT SINCE THE PATIENT HAS GOOD INTRINSIC CONDUCTION, THE PHYSICIAN ELECTED TO REPROGRAM THE DEVICE TO DDI-45PPM. NO OTHER ADVERSE EVENTS HAVE BEEN REPORTED. THIS PRODUCT ISSUE WILL BE UPDATED IF ADDITIONAL INFORMATION IS RECEIVED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT A LATITUDE RED ALERT WAS GENERATED FROM THIS LEAD DUE TO LOW SENSING MEASUREMENTS. R-WAVE MEASUREMENTS AT IMPLANT WERE 10MV AND ARE CURRENTLY 1.5MV. ADDITIONALLY, THERE IS NO CAPTURE AT MAXIMUM DEVICE OUTPUT AND LEAD DISLODGEMENT IS SUSPECTED. ATRIAL NOISE WAS ALSO NOTED AND THE PATIENT WAS SHORT OF BREATH, POSSIBLY DUE TO LOSS OF AV SYNCHRONY. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
146555 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0184

Patients

Seq Age Sex Outcome Treatment
1 93 YR H210| 0185| 0184| N119| 4087| 4543